Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial.
Roger S ZouYunfeng RuanBuu TruongRomit BhattacharyaMichael T LuJúlia KarádyRachel BernardoPhoebe FinneranWhitney E HornsbyKathleen V FitchHeather J RibaudoMarkella V ZanniPamela S DouglasSteven K GrinspoonAniruddh Pradip PatelPradeep NatarajanPublished in: Journal of the American Heart Association (2024)
URL: https://www.reprievetrial.org; Unique identifier: NCT02344290.
Keyphrases
- cardiovascular disease
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- phase iii
- study protocol
- hepatitis c virus
- hiv aids
- men who have sex with men
- phase ii
- clinical trial
- cell therapy
- type diabetes
- cardiovascular risk factors
- south africa
- cardiovascular events
- randomized controlled trial
- open label
- stem cells
- bone marrow
- metabolic syndrome
- double blind
- placebo controlled